Friday, July 10, 2026

Drug profile · INN

influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)

influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted) (FOCETRIA) is an FDA-listed pharmaceutical active ingredient.

EMA: unknown Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)
Class
Antiinfectives for systemic use (J07)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted) (FOCETRIA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)
Brand FOCETRIA
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02

Approval history

Authority Status Date
EMA unknown

Pipeline programs

  1. Avian_inf_vacc_THL20 Approved · George Institute for · Avian influenza and seasonal influenza

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)?

influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted) (FOCETRIA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)?

FOCETRIA is a marketed brand name for influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.